Veriskin is a start-up medical device company developing new tools for primary care practitioners and dermatologists to facilitate evaluation of suspect skin lesions for cancer. Veriskin's mission is to improve patient outcomes and to reduce healthcare costs by improving diagnostic accuracy. From Veriskin's headquarters in San Diego, California, Chief Executive Officer, Mirianas Chachisvilis, PhD, leads a world-class team of scientists, engineers, physicians, regulatory and commercialization experts located throughout the United States, United Kingdom and Germany. TruScore is a non-invasive, hand-held device that uses patented technology and artificial intelligence to detect skin cancer within minutes. The TruScore device is investigational and is not currently available for sale.
Looking for a particular Veriskin employee's phone or email?
The Veriskin annual revenue was $2 million in 2026.
1 people are employed at Veriskin.
Veriskin is based in San Diego, California.
The NAICS codes for Veriskin are [62151, 621, 339, 62, 33, 6215].
The SIC codes for Veriskin are [38, 384].